Search results
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 2 days agoWho should wait, and who should get vaccinated now? The CDC advises that everyone ages 5 and older...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks· 3 hours agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against ...
FDA Tells Vaccine Makers to Target New COVID Variant for Fall
WFMZ Eastern Pennsylvania and Western New Jersey· 21 hours agoCOVID vaccine makers will be advised to update their shots to target the KP.2 variant, an offshoot...
FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot
Reuters via Yahoo News· 14 hours agoThe Food and Drug Administration's change in recommendation, in an update dated Thursday, comes even...
Moderna’s New Flu-COVID Combi mRNA Vaccine Outperforms Separate Shots In Trials
IFLScience· 4 days agoModerna became a household name thanks to the success of its mRNA vaccine against COVID-19. Along...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA TODAY via Yahoo News· 2 days agoDuring the Vaccines and Related Biological Products Advisory Committee, health experts from vaccine manufacturers Pfizer, Moderna and ...
Novavax seeks FDA nod for updated COVID-19 vaccine By Investing.com
Investing.com· 14 hours agoFood and Drug Administration (FDA) for its updated JN.1 COVID-19 vaccine, NVX-CoV2705, for...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 2 days agoNovavax will also receive tiered royalties on sales. Sanofi also made a $70 million investment in...
Another COVID vaccine? Yes, and here’s why
Denver Post· 4 days agoVaccine manufacturers Pfizer and Moderna say they were prepared to make updated vaccines available in August, pending final FDA approval ...
Is It Too Late to Buy Pfizer Stock?
Motley Fool via Yahoo Finance· 21 hours agoTo make matters worse, the forces behind this purported decline do not imply room for recovery. As shown on the chart, Pfizer's performance during the...